Xconomy: Agenda

Tuesday, December 18

5:00 – 6:00	Registration & Networking
6:00 – 6:05	Welcome and Opening Remarks Bob Buderi, Xconomy
6:05 – 6:15	Spotlight Talk Maria Gotsch, Partnership Fund for NYC
6:15 – 6:45	The Rgenix Story Three brothers spun Rgenix out of Rockefeller University based on a technology meant to uncover cancer targets that others haven’t been able to find. It just raised a $40 million Series C and has a drug in human testing Masoud Tavozoie, Rgenix
6:45 – 7:15	The Quentis Therapeutics Story Formed from the labs of former Weill Cornell Medicine dean Laurie Glimcher, Quentis is developing cancer drugs that counteract a method cells use to respond to stress. The startup is a product of Highline Therapeutics, a New York biotech incubator run by Versant Ventures Carlo Rizzuto, Quentis Therapeutics; Versant Ventures Michael Aberman, Quentis Therapeutic
7:15 – 7:45	The Flatiron Health Story Started by two young New York entrepreneurs, Nat Turner and Zach Weinberg, this developer of cancer-specific software was sold to Roche for $1.9 billion earlier this year. Bobby Green, Flatiron Health Marta Bralic Kerns, Flatiron Health
7:45 – 8:45	Networking Reception

Please note that this schedule is subject to change.